The Best Minerals and Vitamins for Acne Treatment

Minerals and vitamins have been increasingly investigated for their potential roles in the management of acne vulgaris, either as adjuncts to conventional therapies or in milder cases as standalone treatments. Acne is a multifactorial inflammatory condition involving increased sebum production, follicular hyperkeratinization, Cutibacterium acnes proliferation, and inflammation. Certain micronutrients have demonstrated anti-inflammatory, antioxidant, and sebostatic properties that may target these pathophysiologic pathways.

Zinc is one of the most extensively studied minerals in acne management. It possesses anti-inflammatory, antibacterial, and immune-modulating effects, and may inhibit C. acnes growth and reduce neutrophil chemotaxis. Both oral and topical zinc preparations have been evaluated in clinical trials, with oral zinc sulfate or gluconate showing modest improvement in inflammatory lesion counts, particularly in patients with mild to moderate acne. However, gastrointestinal upset and variability in absorption limit its widespread use. Topical zinc, often combined with erythromycin or niacinamide, may also reduce inflammatory lesions, though results are inconsistent.

Vitamin A derivatives (retinoids) are the most well-established vitamin-based treatment in acne, with topical agents like tretinoin, adapalene, and tazarotene acting on retinoic acid receptors to normalize keratinization and reduce inflammation. However, non-prescription vitamin A supplements are sometimes promoted for acne, despite limited evidence. High doses can lead to toxicity, including hepatotoxicity and teratogenicity, and should not be recommended without clinical supervision.

Vitamin D plays a role in immune regulation and keratinocyte differentiation, and deficiency has been associated with increased acne severity in some observational studies. Supplementation may be considered in deficient individuals, though controlled trials have not established a direct therapeutic benefit for acne treatment.

Niacinamide (vitamin B3) is increasingly used both topically and orally due to its anti-inflammatory, sebostatic, and skin barrier-supporting properties. Topical niacinamide (typically 2–5%) has shown benefit in reducing papular and pustular lesions and may serve as a gentler alternative or adjunct to topical antibiotics and retinoids. Its favorable tolerability makes it suitable for sensitive or combination therapy regimens. Other micronutrients, such as selenium, vitamin E, and omega-3 fatty acids, have shown potential roles in modulating inflammation and oxidative stress associated with acne, but robust clinical data remain limited.

Pharmacists play a key role in evaluating evidence-based supplement use, screening for deficiencies, and counseling patients on safe dosages, potential interactions, and unregulated over-the-counter acne supplements, many of which contain megadoses of fat-soluble vitamins or herbal components with unclear efficacy and safety. For patients interested in integrative approaches, pharmacists can support the safe incorporation of micronutrients into acne treatment regimens while emphasizing that these interventions are best used as adjuncts, not replacements, for guideline-based therapy.

Dreno B, Thiboutot D, Gollnick H, et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol. 2014;24(3):330–334. doi:10.1684/ejd.2014.2340

Abdel Fattah NS, Atef MM, Al-Quraishy S. Topical and oral zinc therapy in the treatment of acne vulgaris: a systematic review. Dermatol Res Pract. 2020;2020:5704219. doi:10.1155/2020/5704219

Al-Shobaili HA, Alzolibani AA, Al Robaee AA, et al. Vitamin D status in acne vulgaris: implications for pathogenesis and treatment. Dermatol Online J. 2014;20(11):13030/qt6dm8p8jc

Hegazy RA, Darwish DA. Vitamin D status and efficacy of vitamin D therapy in acne vulgaris patients: a case-control study. Dermatoendocrinol. 2013;5(1): 250–255. doi:10.4161/derm.24808

Kim MH, Kim SN, Lee YW, Choe YB, Ahn KJ. The effects of topical 4% nicotinamide on inflammatory acne vulgaris: a randomized controlled trial. Int J Dermatol. 2013;52(12):1547–1553. doi:10.1111/ijd.12199

Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine. Benef Microbes. 2011;2(2):111–119. doi:10.3920/BM2011.0012